The next two day course "Update on Pharmacoeconomics in the Irish Healthcare Setting 2014" is scheduled to take place on 3rd and 4th March 2014.
The NCPE do not recommend reimbursement of Subcutaneous Abatacept (Orencia®) at the submitted price.
The NCPE do not recommend pregabalin as a cost effective treatment for neuropathic pain.